BioHealth News
NIH cancer physician-scientist Christopher Hourigan joins Virginia Tech to lead research in Washington, D.C.
A globally recognized physician-scientist who studies and treats blood cancer is joining Virginia Tech to lead cancer research in Washington, D.C., said Michael Friedlander,…
Read More
Surviving and Thriving: John Sackett, Executive Vice President & COO of Adventist Healthcare, and a 67-Year-Old Cystic Fibrosis (CF) Survivor, Offers Perspectives on CF Life Science Innovation with Rich Bendis on BioTalk
ROCKVILLE, MARYLAND, April 1, 2024 - BioHealth Innovation, Inc. (BHI) is delighted to present a compelling episode on its podcast, BioTalk with Rich Bendis, titled…
Read More
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet
Amsterdam, March 15, 2024 – The government of the Netherlands has allocated €200 million from the country’s National Growth Fund for a public-private consortium that…
Read More
CNBC – Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding…
Read More
AMPEL BioSolutions’ Lupus Test Launches to Predict Flares & Drug Targets
CHARLOTTESVILLE, VA – March 26, 2024 – AMPEL BioSolutions announces a breakthrough in personalized precision medicine that will revolutionize the way doctors manage the autoimmune disease Lupus. Revealed…
Read More
Building Baltimore’s Future: Kory Bailey and the UpSurge Vision on BioTalk
Join us in this episode of BioTalk with Rich Bendis as we delve into the Baltimore ecosystem with Kory Bailey, Chief Ecosystem Officer (CEO)…
Read More
WBJ: Germantown Precigen Inc. biotech expands manufacturing capacity, headcount ahead of potential product launch
Germantown’s Precigen Inc., a clinical-stage biotech developing gene and cell therapies for cancers and other diseases, is taking steps to get an experimental treatment…
Read More
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities AstraZeneca has entered into a definitive agreement to…
Read More
TEDCO Invests in Innate Technologies, Inc.
COLUMBIA, Md. (March 20, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Maryland Equity Investment Fund (MEIF) investment in…
Read More
Clasp Therapeutics Launches With $150 Million to Pioneer Precision Immuno-Oncology Using Next-Generation T Cell Engagers With Unparalleled Specificity
CAMBRIDGE, Mass. & ROCKVILLE, Md.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T cell engagers (TCEs), launched today with…
Read More
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
CEL-4000 may deliver safe and effective therapy for RA by rebalancing the inflammatory response, without weakening important immune defense mechanisms, risking infections or cancer,…
Read More
Biofactura, Inc. Expands presence at Riverside Tech Park in Frederick, Maryland to 17,520 Square Feet
Biotechnology company consolidates operations in business community and expects to employ over 50 engineers, scientists, quality-control professionals, and related positions FREDERICK, Md., March 20,…
Read More
Built in Baltimore: CoapTech, Inc. Announces Market Launch of its Second Generation Magnetic Balloon Catheter for the PUMA-G System
BALTIMORE, MD, March 19, 2024 –, CoapTech, Inc., a medical device company delivering transformative solutions for minimally-invasive surgery, announced today the market launch and…
Read More
Transforming Healthcare: Insights from John Sackett, Adventist Healthcare COO on BioTalk
Discover the Future of Healthcare with John Sackett, Executive Vice President & COO of Adventist Healthcare, on BioTalk with Rich Bendis. In this episode,…
Read More
Bill Enright, CEO at Barinthus Biotherapeutics, reveals the philosophy that built his biotech business
Navigating the uncertain road of entrepreneurshipThis year marks the year of the dragon in Chinese culture. The dragon symbolises nobility, good fortune, and vitality…
Read More